Literature DB >> 21704229

Proteolytic control of the oncoprotein transcription factor Myc.

Lance R Thomas1, William P Tansey.   

Abstract

The c-Myc oncogene encodes a multifunctional transcription factor that directs the expression of genes required for cell growth and proliferation. Consistent with its potent growth-promoting properties, cells have evolved numerous mechanisms that limit the expression and activity of Myc. One of the most prominent of these mechanisms is proteolysis, which destroys Myc within minutes of its synthesis. The rapid and controlled destruction of Myc keeps its levels low and precisely tied to processes that regulate Myc production. In this review, we discuss how Myc protein stability is regulated and the influence of Myc proteolysis on its function. We describe what is known about how Myc is destroyed by ubiquitin (Ub)-mediated proteolysis, attempt to rationalize the role of different Ub-protein ligases and deubiquitylating enzymes (dUbs) in the regulation of Myc stability, and detail how these processes go awry in cancer. Finally, we discuss how our understanding of Myc regulation by the ubiquitin-proteasome system (UPS) can expose strategies for therapeutic intervention in human malignancies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704229     DOI: 10.1016/B978-0-12-386469-7.00004-9

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  50 in total

1.  Artemisitene suppresses tumorigenesis by inducing DNA damage through deregulating c-Myc-topoisomerase pathway.

Authors:  Jian Chen; Wenjuan Li; Ke Cui; Kaiyuan Ji; Shuxiang Xu; Yang Xu
Journal:  Oncogene       Date:  2018-05-24       Impact factor: 9.867

2.  The Drosophila ubiquitin-specific protease Puffyeye regulates dMyc-mediated growth.

Authors:  Ling Li; Sarah Anderson; Julie Secombe; Robert N Eisenman
Journal:  Development       Date:  2013-10-30       Impact factor: 6.868

3.  Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation.

Authors:  John K Simmons; Aleksandra M Michalowski; Benjamin J Gamache; Wendy DuBois; Jyoti Patel; Ke Zhang; Joy Gary; Shuling Zhang; Snehal Gaikwad; Daniel Connors; Nicholas Watson; Elena Leon; Jin-Qiu Chen; W Michael Kuehl; Maxwell P Lee; Adriana Zingone; Ola Landgren; Peter Ordentlich; Jing Huang; Beverly A Mock
Journal:  Mol Cancer Ther       Date:  2017-05-18       Impact factor: 6.261

Review 4.  MYC cofactors: molecular switches controlling diverse biological outcomes.

Authors:  Stephen R Hann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

5.  mTOR complex 1 controls the nuclear localization and function of glycogen synthase kinase 3β.

Authors:  Stephen J Bautista; Ivan Boras; Adriano Vissa; Noa Mecica; Christopher M Yip; Peter K Kim; Costin N Antonescu
Journal:  J Biol Chem       Date:  2018-07-30       Impact factor: 5.157

6.  Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression.

Authors:  Seung-Myoung Son; Sang-Yun Ha; Hae-Yong Yoo; Dongryul Oh; Seok-Jin Kim; Won-Seog Kim; Young-Hyeh Ko
Journal:  Mod Pathol       Date:  2016-09-30       Impact factor: 7.842

7.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

8.  Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.

Authors:  Cheryl M Koh; Ekta Khattar; Shi Chi Leow; Chia Yi Liu; Julius Muller; Wei Xia Ang; Yinghui Li; Guido Franzoso; Shang Li; Ernesto Guccione; Vinay Tergaonkar
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

9.  Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma.

Authors:  Ying Gu; Jiawei Zhang; Xiaoxiao Ma; Byung-Wook Kim; Hailong Wang; Jinfan Li; Yi Pan; Yang Xu; Lili Ding; Lu Yang; Chao Guo; Xiwei Wu; Jun Wu; Kirk Wu; Xiaoxian Gan; Gang Li; Ling Li; Stephen J Forman; Wing-Chung Chan; Rongzhen Xu; Wendong Huang
Journal:  Cancer Cell       Date:  2017-07-10       Impact factor: 31.743

Review 10.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.